Synopsis
Are our regulatory agencies doing their best to ensure drug safety? Or are they buckling to corporate pressure to market lucrative new drugs before they are adequately tested? These are questions raised in DRUG DEALS: THE BRAVE NEW WORLD OF PRESCRIPTION DRUGS.